Warner Chilcott Licenses Psoriasis Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Warner Chilcott has agreed to license Dovobet from LEO Pharma S/A upon FDA approval
You may also be interested in...
FDA Clears Warner Chilcott’s Scalp Treatment
Psoriasis salve lifts first-quarter revenue, ahead of $40 million milestone payout to Denmark firm Leo Pharma.
Italy Leads European Push Into Conditional Reimbursement
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.